Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer

SIMPLE SUMMARY: The nomogram derived from the pivotal phase III NAPOLI-1 study could predict the overall survival in gemcitabine-refractory metastatic pancreatic cancer treated with liposomal irinotecan plus fluorouracil and leucovorin. However, the NAPOLI-1 nomogram has not been validated in a real...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yung-Yeh, Chiang, Nai-Jung, Yang, Yi-Hsin, Yen, Chia-Jui, Bai, Li-Yuan, Chiu, Chang-Fang, Chuang, Shih-Chang, Yang, Shih-Hung, Chou, Wen-Chi, Chen, Jen-Shi, Chiu, Tai-Jan, Chen, Yen-Yang, Chan, De-Chuan, Peng, Cheng-Ming, Chiu, Sz-Chi, Li, Chung-Pin, Shan, Yan-Shen, Chen, Li-Tzong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954707/
https://www.ncbi.nlm.nih.gov/pubmed/36831353
http://dx.doi.org/10.3390/cancers15041008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954707/
https://www.ncbi.nlm.nih.gov/pubmed/36831353
http://dx.doi.org/10.3390/cancers15041008

Ejemplares similares